Filing Flows › Accendra Health (ACH) › Q4 2025
Accendra Health (ACH) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 20, 2026
Accendra Health (ACH) reported revenue of $709M for the fourth quarter 2025 (Q4 2025), +2% from a year earlier and +2% from the quarter before. Operating margin was 2.9%, net loss $56.3M (7.9% of revenue).
Accendra Health, Q4 2025: revenue $709M (+2% year over year), operating margin 2.9%, net loss $56.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $709M | +2% | +2% |
| Operating profit | $20.9M | -21% | — |
| Net earnings | −$56.3M | — | — |
What changed
Revenue was $709.0M in Q4 2025, up 2% year over year and up 2% from the previous quarter. Diabetes was the largest line at 29% of revenue.
Operating profit was $20.9M, a 2.9% margin (up 42.2 points year over year). The quarter ended with a net loss of $56.3M, narrower than the previous quarter's $150.3M loss. Net interest and other expense of $75.8M was the main reason.
Questions
What was Accendra Health's revenue in the fourth quarter 2025?
Accendra Health (ACH) reported revenue of $709M for the fourth quarter 2025 (Q4 2025), +2% from a year earlier and +2% from the quarter before.
Was Accendra Health profitable in the fourth quarter 2025?
Operating profit was $20.9M (2.9% of revenue) and net loss $56.3M.
Source: Accendra Health 10-K on SEC EDGAR.